Vicarious Surgical/RBOT

$0.31

-4.22%
-
1D1W1MYTD1YMAX

About Vicarious Surgical

Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.2 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.

Ticker

RBOT

Sector

Healthcare

Trading on

NYSE

Industry

Software & Programming

CEO

Adam Sachs

Employees

131

Headquarters

Waltham, United States

RBOT Metrics

BasicAdvanced
$57.33M
Market cap
-
P/E ratio
-$0.51
EPS
1.15
Beta
-
Dividend rate
$57.33M
1.14517
$2.46
$0.20
617.42K
13.867
-54.64%
-68.01%
-58.14%
0.584
0.585
-1,168.6%

What the Analysts think about RBOT

Analyst Ratings

Majority rating from 4 analysts.
Hold

Price Targets

Average projection from 3 analysts.
232.26% upside
High $1.50
Low $0.60
$0.31
Current price
$1.03
Average price target

RBOT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$0
-
Net income
$-13.1M
-16.56%
Profit margin
0%
-

RBOT Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 52%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.21
-$0.12
-$0.10
-$0.06
-
Expected
-$0.14
-$0.14
-$0.14
-$0.13
-$0.10
Surprise
55.56%
-15.79%
-29.82%
-52%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Vicarious Surgical stock?

Vicarious Surgical (RBOT) has a market cap of $57.33M as of April 13, 2024.

What is the P/E ratio for Vicarious Surgical stock?

The price to earnings (P/E) ratio for Vicarious Surgical (RBOT) stock is 0 as of April 13, 2024.

Does Vicarious Surgical stock pay dividends?

No, Vicarious Surgical (RBOT) stock does not pay dividends to its shareholders as of April 13, 2024.

When is the next Vicarious Surgical dividend payment date?

Vicarious Surgical (RBOT) stock does not pay dividends to its shareholders.

What is the beta indicator for Vicarious Surgical?

Vicarious Surgical (RBOT) has a beta rating of 1.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Vicarious Surgical stock price target?

The target price for Vicarious Surgical (RBOT) stock is $1.03, which is 232.26% above the current price of $0.31. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Vicarious Surgical stock

Buy or sell Vicarious Surgical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing